We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to T-cell transduction and culture
  • Microfluidic alginate sponge activates and transduces T cells
  • Technology overview
  • Adoptive T-cell therapy (ACT)
  • RetroNectin FAQs
  • Hematopoietic cell transduction
  • T-cell expansion
  • Serum-free T-cell culture
  • CultiLife culture bags protocol
  • Cytokine analysis
Home › Learning centers › Gene function › T-cell transduction and culture › Microfluidic alginate sponge activates and transduces T cells

Gene function

  • Gene editing
    • Gene editing product finder
    • Gene editing tools and information
      • sgRNA design tools
      • Tools for successful CRISPR/Cas9 genome editing
      • Gene editing posters
      • Customer data for Guide-it products
      • How to design sgRNA sequences
      • Introduction to the CRISPR/Cas9 system
      • Gene editing of CD3+ T cells and CD34+ HSCs
    • CRISPR/Cas9 knockouts
      • Mutation detection kit comparison
      • Screening for effective guide RNAs
      • Monoallelic versus biallelic mutants
      • Indel identification kit for mutation characterization
    • CRISPR/Cas9 knockins
      • Choosing an HDR template format
      • Homology-directed repair FAQs
      • Mouse CRISPR knockin protocol
      • Site-specific gene knockins using long ssDNA
      • Efficient CRISPR/Cas9-mediated knockins in iPS cells
      • Oligo design tool for detecting precise insertions
        • Oligo design tool user guide (insertions)
    • Genome-wide screening
      • CRISPR library screening
      • CRISPR library screening webinar
      • Phenotypic screen using sgRNA library system
    • Creating and screening for SNPs
      • SNP detection with knockin screening kit
      • Oligo design tool for SNP screening
        • Oligo design tool user guide (SNPs)
      • Sign up: SNP engineering webinar
      • Guide-it SNP Screening Kit FAQs
    • CRISPR/Cas9 delivery methods
      • Electroporation-grade Cas9 for editing in diverse cell types
      • CRISPR/Cas9 gene editing with AAV
      • CRISPR/Cas9 gesicles overview
      • Cas9 Gesicles—reduced off-target effects
      • sgRNA-Cas9 delivery to many cell types
      • Tet-inducible Cas9 for gene editing
    • Cre recombinase
      • Control your Cre recombinase experiments
      • Fast Cre delivery with gesicle technology
  • Viral transduction
    • Recombinant virus comparison
    • Product finder
    • Transduction posters
    • Lentivirus
      • Lenti-X Transduction Sponge overview
        • Lenti-X Transduction Sponge app note primary cells
        • Lenti-X Transduction Sponge tech note
        • Lenti-X Transduction Sponge compatible cell types
      • Webinars
        • Webinar: Cellular reprogramming of cancer cells for immunotherapy
        • Lentiviral particles webinar
      • Customizable SARS-CoV-2 pseudovirus
      • Lenti-X FAQs
      • Lentiviral workflow
      • Lentiviral products guide
      • Lentivirus biosafety
      • Lentiviral tips
      • Lentiviral vectors
      • Lenti-X packaging
      • High-throughput lentivirus production
      • Lenti-X Concentrator
      • Lentiviral titration
      • Lenti-X GoStix Plus video protocols
      • Lenti-X GoStix Plus FAQs
      • Rapid lentivirus titration by p24 ELISA
      • Lentiviral particles
      • Lentiviral particles—fluorescent
      • Lentiviral particles FAQs
    • Retrovirus
      • Retroviral products
      • Retro-X FAQs
      • Retro-X packaging
      • Retro-X Concentrator
    • Adeno-associated virus
      • AAV workflow
      • AAV products
      • AAV FAQs
      • AAV tech notes
        • Customer data: Purified AAV9 delivery (mouse brain)
        • Customer data: Purified AAV9 delivery (songbird brain)
        • Serotype-independent AAV vector purification
        • Customer data: Purified AAV2 delivery (mouse brain)
      • AAV videos
        • AAV2 purification video
        • AAVpro "All Serotypes" protocols
      • AAVpro Concentrator overview
    • Adenovirus
      • Adenoviral FAQs
      • Adenoviral products
      • Fastest, easiest adenoviral system ever
      • Tet-inducible adenovirus
      • Adenovirus purification kits
      • Adenovirus purification mega-scale
      • Adenovirus rapid titer
      • Adenoviral titration
  • T-cell transduction and culture
    • Microfluidic alginate sponge activates and transduces T cells
    • Technology overview
    • Adoptive T-cell therapy (ACT)
    • RetroNectin FAQs
    • Hematopoietic cell transduction
    • T-cell expansion
    • Serum-free T-cell culture
    • CultiLife culture bags protocol
    • Cytokine analysis
  • Inducible systems
    • iDimerize systems
      • Inducible protein-protein interactions—iDimerize systems
      • iDimerize systems journal club
      • iDimerize in vivo protocol
      • iDimerize systems citations
      • ARGENT cell signaling regulation kits from ARIAD
    • ProteoTuner systems
      • ProteoTuner technology overview
      • ProteoTuner citations
      • Inducible protein stabilization systems product selection guide
    • Tet-inducible systems
      • Tet systems product selection guide
      • Tet systems overview
      • Tet-One technology overview
      • Tet-On 3G plasmid system kit components
      • Tet-On 3G lentiviral system kit components
      • Tet system webinars
  • Transfection reagents
    • Xfect Transfection Reagent
    • Transfection tips
    • Cell lines transfected with the Xfect reagent
    • Protein transfection FAQs
    • Xfect RNA Transfection Reagent
    • Transfection reagent products
    • Protocol: transfection of cerebellar slice cultures with Xfect reagent
    • Calcium phosphate transfection of neurons
  • Fluorescent proteins
    • Fluorescent protein vector finder
    • Fluorescent protein excitation and emission maxima
    • Fluorescent protein antibodies selection guide
    • Fluorescent protein antibody citations
      • GFP antibody citations
      • RFP antibody citations
    • Fluorescent protein quick guide
    • Fluorescent retroviral expression vectors
    • Verify miRNA expression
    • Find EGFP vector alternatives
  • Cell biology assays
    • Technical notes
      • Cell viability and proliferation measurement
    • Citations
New products
Need help?
Contact Sales
Tech Note

Microfluidic alginate sponge activates and transduces T cells

The Lenti‑X T‑Cell Transduction Sponge (T‑cell sponge) is a modified version of our Lenti‑X Transduction Sponge that is optimized specifically for human T cells. The T-cell sponge expedites and streamlines T‑cell lentiviral transduction for research applications, including CAR T‑cell therapy (Agarwalla et al. 2022).

Benefits of the T‑cell sponge supported by the data below:

  • Expedited CAR T‑cell development by combining transduction and activation into one step
  • Reduction of CAR T-cell production time by days
  • Consistent activation across a range of multiplicity of infection (MOI) values
  • Increased or comparable transduction efficiency and cell viability compared to other transduction methods
  • Effective scaling (from 2 x 106–10 x 106 cells)
  • Minimal phenotypic and transcriptomic impact to the resulting cells
  • Reduction in the amount of virus required
  • Omission of T‑cell isolation by using PBMCs directly as T‑cell source in the T-cell sponge

Applications

  • Lentiviral transduction for:
    • T‑cell engineering
    • Gene editing
    • Gene and protein expression
    • Therapeutic model generation
    • Whole-genome screening
    • CAR T‑cell therapy research using lentivirus for gene modification
  • Virus-like particles (VLPs) transduction
Introduction Results Conclusions References

Introduction  

The T‑cell sponge is a dissolvable macroporous alginate matrix (Figure 1, Panel A) that allows users to activate and transduce T cells, achieving lentiviral transduction efficiency comparable or superior to traditional methods, with only one hands-on step. The alginate microfluidics system promotes transduction by facilitating colocalization of cells and lentiviral particles (Figure 1, Panel B) without the use of expensive instrumentation.

Figure 1. Structure and format of the T‑cell sponge. Panel A. The Lenti‑X T‑Cell Transduction Sponge is a lyophilized alginate-based cake with a structure of ~1 cm in diameter and ~0.5 cm in depth to which a mixture of cells and viruses are added, resulting in high lentiviral transduction efficiency. Every sponge features a complex microfluidic pore structure with pore sizes ranging from 20–300 µm. The scanning electron microscopy image shown is at 150X magnification. Panel B. Schematic showing the macroporous structure, which enables microfluidics-based colocalization of the cells and virus.

The T‑cell sponge is embedded with an optimized blend of T‑cell activation reagents (rhIL‑2 and anti-human CD3 and CD28 antibodies), allowing T‑cell activation and transduction in a single hands-on step. By incorporating the T‑cell sponge into workflows, users can avoid time-consuming spinoculation and harsh chemical transduction enhancers while minimizing cell handling, which can affect viability. Additionally, the effective colocalization of cells and lentiviral particles allows users to reduce the total amount of virus required, which saves users money by decreasing the cost per reaction.

Results  

T‑cell activation remains consistent and comparable to other activation methods

The T‑cell sponge was evaluated for T‑cell activation while being transduced at multiple MOIs. This activation was compared against a CD3/CD8 conjugate method and an unstimulated control (Figure 2). Activation was quantified as the percentage of cells expressing CD69+.

Figure 2. T‑cell activation analysis at different MOIs. Activation, determined by CD69+ expression at 48 hr, was compared across an unstimulated control and two methods: CD3/CD28 conjugate and the Lenti‑X T‑cell Transduction Sponge (T‑cell sponge). The CD3/CD28 conjugate was evaluated at MOI 5; the T‑cell sponge was evaluated at MOI of 0, 5, and 10. An average across the samples for the T‑cell sponge was calculated (final column).

These data support the use of the T‑cell sponge for T‑cell activation with comparable or superior activation compared to the CD3/CD28 conjugate method.

T‑cell sponge shows improved transduction efficiency compared to spinoculation, which requires an additional activation step

Lentiviral transduction of T cells can be done via spinoculation, a centrifugation method that increases transduction efficiency by modulating cytoskeletal dynamics in response to centrifugal stress (Guo et al. 2011). However, spinoculation is time-consuming and can result in decreased cell viability.

The T‑cell sponge increases transduction efficiency by gently bringing viral particles and T cells closer together—without the need to expose cells to centrifugal force that can affect T-cell viability—while also activating T cells with its embedded CD3 and CD28 antibodies.

To compare the two methods (spinoculation vs. T‑cell sponge), transduction efficiency was evaluated at MOIs of 0, 5, and 10 over 11 days using GFP+ expression (Figure 3).

Figure 3. Transduction efficiency comparison between the T‑cell sponge and spinoculation with polybrene (Pb). Transduction efficiency was measured by GFP+ expression at MOIs of 0 (control), 5, and 10 at Days 2, 4, 7, 9, and 11. Day 7 data are listed above the 7‑day bar for both methods. The use of the T‑cell sponge consistently results in higher transduction efficiency compared to spinoculation and Pb at Days 7, 9, and 11.

The T‑cell sponge consistently results in higher transduction efficiency at Days 7, 9, and 11 compared to spinoculation, supporting the use of the T‑cell sponge as a gentle method to increase transduction efficiency, while also activating T cells with the embedded anti-human CD3 and CD28 antibodies.

T‑cell transduction efficiency remains consistent and high across a range of cell numbers

To ensure the efficacy of transduction for a wide range of cell number inputs, the T‑cell sponge was tested across a five-fold range (2 x 106–10 x 106 cells, Figure 4). GFP-expression data were collected at 2, 4, 7, and 9 days for the T‑cell sponge and for the cells transduced via spinoculation. For both transduction methods, the percentage of GFP-expressing cells increases with time and then plateaus (Day 2 shows the lowest percentage of cells expressing GFP, and Days 7 and 9 show the highest).

Figure 4. Transduction efficiency using the Lenti‑X T‑Cell Transduction Sponge during scaling. The T‑cell sponge was tested with input amounts from 2 x 106–1 x 107 cells. Spinoculation was tested at 4 x 106 and 1 x 107 cells. GFP-expression data were collected at 2, 4, 7, and 9 days for the T‑cell sponge and for the cells transduced via spinoculation. All reactions occurred at MOI 5.

The percentage of GFP-expressing cells following transduction remains consistent for 4 x 106–1 x 107 cell ranges using the T‑cell sponge. However, T cells transduced via spinoculation show considerable variation between the 4 x 106 –1 x 107 cell ranges. These data support the use of the T‑cell sponge for transduction across a wide range of inputs, which can all be accomplished in a single well. Less efficiently, transduction via plated spinoculation requires multiple wells of a 24‑well plate to maintain cell density requirements.

The advantages of the T‑cell sponge give researchers the flexibility to scale up or down and activate their T cells at the same time.

Sponge-transduced T cells exhibit a normal phenotype

Post-transduced cells were analyzed after nine days to determine if phenotype or cellular exhaustion markers differed between cells transduced via spinoculation and those transduced using the T‑cell sponge (Figure 5). The ratio of CD4+ to CD8+ cells was determined, and LAG‑3 and PD‑1 expression were used to evaluate cell exhaustion.

Figure 5. T cells transduced with the transduction sponge are phenotypically the same as spinoculated cells. 4 x 106 human primary T cells were mixed with a lentivirus expressing ZsGreen1 at the indicated MOIs and added to the Lenti‑X T‑Cell Transduction Sponge. Spinoculated samples were activated with a CD3/CD28 reagent for two days, then exposed to the lentivirus with polybrene (8 µg/ml), centrifuged at 1,500g for 90 min, and incubated overnight. Panel A. Activated and transduced cells were expanded out for nine days using a G‑Rex24 Well Plate and then analyzed for CD4 and CD8 expression using FACS analysis. Panel B. Activated, transduced, and expanded cells were also analyzed for the presence of exhaustion markers PD‑1 and LAG‑3 using FACS analysis.

The ratio of CD4+ and CD8+ T cells nine days post-transduction remains around 1:1 for T cells transduced with the T‑cell sponge. Spinoculation results in slightly more CD4+ cells than CD8+ cells. Nine days poststimulation exhaustion markers remain relatively low for cells transduced with either method.

These data indicate that the cells activated and transduced by the T‑cell sponge exhibit a normal phenotype and similar exhaustion markers compared to the cells transduced via spinoculation, which requires a separate activation step. While producing T cells with normal phenotypes and similar exhaustion markers to those prepared via spinoculation, the T cells prepared with the T‑cell sponge are ready in substantially less time.

Sponge-transduced T cells exhibit minimal transcriptomic impact

In addition to analyzing T‑cell phenotype, a transcriptomic analysis was also done to determine how transduction with the T‑cell sponge affected gene expression (Figure 6).

Figure 6. Cells transduced with the T‑cell sponge display similar gene expression changes to those transduced by standard methods. 4 x 106 human primary T cells were activated using one of the following methods for two days: T-cell sponge, a CD3/CD28 reagent (“Conjugate”), RetroNectin reagent + anti‑CD3 (“RN + anti‑CD3”), or anti‑CD3/CD28-coated beads (“Beads”). Cells were then transduced with a lentivirus expressing ZsGreen1 at an MOI of 5 in the presence of polybrene (8 µg/ml), followed by centrifugation at 1,500g for 90 min. For the T‑cell sponge transduction, 4 x 106 T cells were mixed with the same lentivirus (MOI = 5), incubated within the sponge for two days, and then released. Data were collected 48 hr post-transduction. RNA was isolated using the SMART‑Seq mRNA LP kit and sequenced on an Illumina® NextSeq® instrument. Heat map and clustering are based on the top 200 most-differentially expressed genes for each activation/transduction condition.

The heat map and hierarchical clustering show differentially expressed genes in activated and transduced cells at 48 hours post-transduction for four activation/transduction methods (Figure 6). The data indicate no significant difference in the expression pattern of the top 200 differentially expressed genes, indicating that the T‑cell sponge is both an effective and transcriptionally inert tool for transducing T cells.

PBMCs can be used as the T‑cell source, saving days during a workflow

Peripheral blood mononuclear cells (PBMCs), obtained from a standard blood draw, contain T cells. The process for isolating T cells from PBMCs for transduction is labor intensive and expensive. The T‑cell sponge is able to remove that isolation step by selectively activating and transducing T cells directly from a PBMC sample.

The efficacy of the T‑cell sponge from PBMC samples was evaluated by comparing cell subtypes pre‑ and post-transduction (Figure 7).

Figure 7. T cells can be specifically activated and transduced when starting with PBMCs with the T‑cell sponge. 1 x 107 unstimulated PBMCs were combined with lentivirus encoding ZsGreen1 at an MOI of 3 and 12, and then directly applied to a T‑cell transduction sponge. After 48 hr, the cells were released from the sponge for further culture and analysis. Panel A. The composition of the PBMC population was assessed by FACS prior to lentiviral transduction with the sponge. Panel B. Transduction efficiency and cell phenotypes were analyzed at 48 hr post-transduction by FACS for ZsGreen1 expression and cell phenotypes.

The data show that the sponge effectively and selectively activates and transduces T cells specifically from PBMC samples, eliminating the need for T‑cell isolation and potentially saving days in the T‑cell engineering and validation workflow.

Conclusions  

The data presented in this technote support the Lenti‑X T‑Cell Transduction Sponge as an effective tool for T‑cell activation and transduction, allowing users to achieve transduction efficiency gains without the use of additional activation steps or chemical enhancers, which can affect cell viability. The T‑cell sponge also minimizes hands-on time and allows users to start from PMBC samples.

  • T‑cell transduction efficiency is better or comparable to difficult and time-consuming spinoculation and does not require an additional activation step
  • Sponge-transduced T cells do not require an additional activation step
  • PBMCs can be used as the T‑cell source, saving days during a workflow
  • T‑cell activation remains consistent and is comparable to other activation methods
  • T‑cell transduction efficiency remains consistent and high across a range of cell numbers
  • Sponge-transduced T cells exhibit a normal phenotype
  • Sponge-transduced T cells exhibit minimal transcriptomic impact

References  

Agarwalla, P. et al. Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR‑T cells. Nat. Biotechnol. 40, 1250–1258 (2022).

Guo, J., Wang, W., Yu, D. & Wu, Y. Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells. J. Virol. 85, 9824–9833 (2011).

Related Products

Cat. # Product Size Price License Quantity Details
631480 Lenti-X™ T-Cell Transduction Sponge 12 Rxns USD $624.00

License Statement

ID Number  
446 Limited Use Label License: Lenti-X Transduction Sponge

This product which you will receive/have received from Takara Bio USA, Inc. (“TBUSA”) includes within it certain materials (“Product”) which are subject to a field limited license between TBUSA and North Carolina State University (“NC State”) and are subject to one or more pending patents including U.S. Patent Application No. 17/917,770 and corresponding foreign patent filings.

As the purchaser of the Product (“Recipient”), Recipient hereby agrees to the following limited use license: Recipient is granted the limited right to use the Product only for ex vivo transduction of cells for internal non-commercial research purposes. The Recipient is strictly prohibited from: (i) transferring the Product its components, and/or materials that incorporate the Product to any third party without TBUSA’s express written permission; (ii) using the ex vivo transduced cells and/or any components thereof in any clinical or therapeutic application without TBUSA’s express written permission; (iii) using the Product for any application other than the ex vivo transduction of cells without NC State’s express written permission; and/or (iv) implanting/inserting the Product within a living organism without NC State’s express written permission.

The Recipient acknowledges and hereby agrees that: (i) if Recipient is interested in implanting/inserting the Product within a living organism and/or in using the Product for applications other than ex vivo transduction of cells, Recipient must obtain a license from NC State, and (ii) NC State is a third-party beneficiary under this limited use label license and has the authority to enforce its provision against the Recipient, at its sole discretion, if the Recipient (a) uses the Product for any application other than the ex vivo transduction of cells, and/or (b) implants/inserts the Product in a living organism. Any use of the Product other than what is expressly granted above, will require an additional license from TBUSA. Any use of the Product for in vivo transduction of cells and/or for implantation/insertion within a living organism, will require a license from NC State. For information relating to obtaining a license from NC State, contact NC State at ncsulicenses@ncsu.edu.

The Lenti-X T-Cell Transduction Sponge expedites and streamlines lentiviral transduction of T cells, bypassing the need for prior activation or spinoculation with chemical enhancers. This innovative approach employs a macroporous alginate matrix infused with an optimized blend of rhIL-2 (100 IU) and anti-human CD3 & CD28 antibodies. This combination with the sponge not only activates T cells but also enhances lentiviral transduction by fostering the co-localization of activated T cells and lentivirus particles.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components Image Data

Back

Lenti-X T-Cell Transduction Sponge workflow

Lenti-X T-Cell Transduction Sponge workflow

Visual overview of the Lenti-X T-Cell Transduction Sponge workflow.

Back

Lenti-X T-Cell Transduction Sponge details

Lenti-X T-Cell Transduction Sponge details

Lenti-X T-Cell Transduction Sponge. Panel A. Sponges (12) in the crush-resistant blister packaging and magnified view of the macroporous cell structure of the alginate. Panel B. Illustrated visualization of colocalization of T cells and virus promoted by the sponge structure.

Back

Effective transduction of human primary T cells

Effective transduction of human primary T cells

Effective T-cell transduction with the Lenti-X T-Cell Transduction Sponge. 4 x 106 human primary T cells were mixed with a lentivirus expressing ZsGreen1 at the indicated MOI and added to the Lenti-X T-Cell Transduction Sponge ("T-cell sponge"). Spinoculated samples were activated with CD3/CD28 ImmunoCult reagent for two days, then exposed to the lentivirus with polybrene (8 µg/ml) and centrifuged at 1,500g for 90 min ("Spinoculation"). Transduction efficiency was assessed by FACS analysis for ZsGreen1 expression at the indicated time points. Displayed percentages show GFP+ expression at seven days.

Back

High viability of human primary T cells after transduction

High viability of human primary T cells after transduction

High T-cell viability after transduction with the Lenti-X T-Cell Transduction Sponge. 4 x 106 human primary T cells were mixed with a lentivirus expressing ZsGreen1 at the indicated infection MOIs and added to the Lenti-X T-cell Transduction Sponge ("T-cell sponge"). Spinoculated samples were activated with CD3/CD28 ImmunoCult reagent for two days, then exposed to the lentivirus with polybrene (8 µg/ml) and centrifuged at 1,500g for 90 min ("Spinoculation"). Viability was assessed at indicated timepoints post-transduction by 7-AAD staining and FACS analysis.

Back

Efficient T-cell activation across a range of MOI values

Efficient T-cell activation across a range of MOI values

Efficient T-cell activation with the Lenti-X T-Cell Transduction Sponge. 4 x 106 human primary T cells were mixed with a lentivirus expressing ZsGreen1 at the indicated multiplicities of infection (MOIs) and added to the Lenti-X T-cell Transduction Sponge ("T-cell sponge") or treated with CD3/CD28 Immunocult reagent ("Conjugate"). Unstimulated cells were used as a control ("Unstim"). After 48 hr, treated cells were assayed for CD69 expression by FACS analysis.

Back

631480: Lenti-X T-Cell Transduction Sponge

631480: Lenti-X T-Cell Transduction Sponge
631478 Lenti-X™ Transduction Sponge 24 Rxns USD $520.00

License Statement

ID Number  
446 Limited Use Label License: Lenti-X Transduction Sponge

This product which you will receive/have received from Takara Bio USA, Inc. (“TBUSA”) includes within it certain materials (“Product”) which are subject to a field limited license between TBUSA and North Carolina State University (“NC State”) and are subject to one or more pending patents including U.S. Patent Application No. 17/917,770 and corresponding foreign patent filings.

As the purchaser of the Product (“Recipient”), Recipient hereby agrees to the following limited use license: Recipient is granted the limited right to use the Product only for ex vivo transduction of cells for internal non-commercial research purposes. The Recipient is strictly prohibited from: (i) transferring the Product its components, and/or materials that incorporate the Product to any third party without TBUSA’s express written permission; (ii) using the ex vivo transduced cells and/or any components thereof in any clinical or therapeutic application without TBUSA’s express written permission; (iii) using the Product for any application other than the ex vivo transduction of cells without NC State’s express written permission; and/or (iv) implanting/inserting the Product within a living organism without NC State’s express written permission.

The Recipient acknowledges and hereby agrees that: (i) if Recipient is interested in implanting/inserting the Product within a living organism and/or in using the Product for applications other than ex vivo transduction of cells, Recipient must obtain a license from NC State, and (ii) NC State is a third-party beneficiary under this limited use label license and has the authority to enforce its provision against the Recipient, at its sole discretion, if the Recipient (a) uses the Product for any application other than the ex vivo transduction of cells, and/or (b) implants/inserts the Product in a living organism. Any use of the Product other than what is expressly granted above, will require an additional license from TBUSA. Any use of the Product for in vivo transduction of cells and/or for implantation/insertion within a living organism, will require a license from NC State. For information relating to obtaining a license from NC State, contact NC State at ncsulicenses@ncsu.edu.

The Lenti-X Transduction Sponge is a macroporous alginate structure that facilitates rapid and efficient lentiviral transduction without spinoculation or the use of a chemical transduction enhancer. It encourages the co-localization of target cells and lentivirus, eliminating biotransport issues associated with standard lentiviral transduction methods. A simple, easy-to-use protocol reduces cell handling and requires smaller total reaction volumes while producing transduction efficiencies that are comparable to or improved over traditional methods.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components Image Data

Back

Lenti-X Transduction Sponge workflow

Lenti-X Transduction Sponge workflow

Simple transduction workflow using the Lenti-X Transduction Sponge. Cells and virus are mixed prior to application to the sponge. The transduction mixture is incubated for 1 hr, followed by the addition of media and overnight incubation for 16–24 hr. No spinoculation is required. The next day, healthy, transduced cells are released using an optimized Release Buffer that depolymerizes the alginate matrix. Cells are then ready for subsequent analysis or continued culture.

Back

Convenient format for use with a 24-well tissue culture plate

Convenient format for use with a 24-well tissue culture plate

The Lenti-X Transduction Sponge comes in a convenient format for use with a 24-well tissue culture plate. Panel A. Each kit comprises 24 individual sponges, each capable of facilitating transduction of up to 1 x 107 cells. Panel B. Every sponge features a complex microfluidic pore structure with pore sizes ranging from 20–300 μm. The image shown is at 150X magnification. Panel C. Simple placement of the transduction sponge into a well before applying the sample. Panel D. The transduction mix, consisting of 1 x 105–1 x 107 cells and virus, is added to the sponge and incubated for 1 hr before the addition of media and incubation for 16–24 hr. Panel E. Cell release is facilitated by transferring the sponge to a 15 ml conical tube and adding Release Buffer, followed by a short wash step.

Back

Transduction efficiency compared to spinoculation

Transduction efficiency compared to spinoculation

The Lenti-X Transduction Sponge facilitates transduction at equivalent levels to spinoculation in multiple cell types. Panel A. 1 x 106 Jurkat cells were transduced with lentivirus expressing ZsGreen1 at the indicated multiplicities of infection (MOIs) using spinoculation or the Lenti-X Transduction Sponge. The spinoculation cultures were centrifuged for 90 min at 1400xg at 32°C in the presence of 8 μg/ml polybrene. All transductions were analyzed at 48 hr post-transduction for ZsGreen1 expression by FACS. Panel B. To further compare sponge transduction to spinoculation ("Spin" in the figure), various cell lines were transduced with ZsGreen1 lentivirus at several MOIs, as described in Panel A.

Back

Increased T-cell transduction efficiency while preserving viability

Increased T-cell transduction efficiency while preserving viability

The Lenti-X Transduction Sponge enhances primary T-cell transduction efficiency while preserving viability. Panel A. Human primary T cells were activated using MHC tetramer, anti-CD3/CD28-coated beads, Retronectin reagent (RN) + CD3, or CD3 only. Activation levels indicated by percentage CD69+ expression at 48 hr are displayed. Then, 1 x 106 activated cells were transduced with lentivirus encoding ZsGreen1 at the specified multiplicity of infection (MOI) using the transduction sponge for 24 hr. FACS analysis was performed at 48 hr post-transduction to determine %ZsGreen1 expression. Panel B. Viability at 48 hr post-transduction as determined by 7-AAD staining and FACS analysis.

Back

Consistent transduction efficiency across varying cell amounts and transduction times with low inter-sponge variability

Consistent transduction efficiency across varying cell amounts and transduction times with low inter-sponge variability

The Lenti-X Transduction Sponge demonstrates consistent transduction efficiency across varying cell amounts and transduction times with low inter-sponge variability. Panel A. Jurkat cells were transduced with a lentivirus encoding ZsGreen1 at specified cell numbers and multiplicities of infection (MOIs) using either a RetroNectin reagent + spinoculation (RN + spin) protocol or the transduction sponge for 24 hr. Panel B. Increasing numbers of Jurkat cells were transduced for 4, 9, 24, or 48 hr using the transduction sponge with a lentivirus expressing ZsGreen1 (MOI=10). Panel C. 1 x 106 Jurkat cells were transduced with lentivirus expressing ZsGreen1 (MOI=2.5) in six replicates weekly for 4 weeks to assess inter-run variability (%CV=12.6). For all experiments, ZsGreen1 expression was analyzed by FACS 48 hr post-transduction to determine %ZsGreen positive cells and mean fluorescence intensity (MFI). The average ZsGreen1 expression across all replicates is shown in red (AVG).

Back

631478: Lenti-X Transduction Sponge

631478: Lenti-X Transduction Sponge


Sample the Lenti-X T-Cell Transduction Sponge

Evaluate the new T-cell sponge in your research project.

  • Activate and transduce T cells in one step
  • Skip labor-intensive, time-consuming spinoculation
  • End reliance on chemical-based enhancers like polybrene
Request a sample

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2026 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2026 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial omics
  • Trekker resources
  • Seeker resources
  • Spatial bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Clontech, TaKaRa, cellartis

  • Products
  • Next-generation sequencing
  • COVID-19 research
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial omics
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial omics
  • Trekker resources
  • Seeker resources
  • Spatial bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us